gip/glp-1 drugs Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements TrimRX | GLP-1 vs GIP:
Description
Another limitation is that for thyroid cancer, reporting specifically the cases of MTC vs
Interesting to see how this behaves as a commercial product
Conclusions In this real-word study, GLP-1RA was associated with a lower risk of AF compared with DPP4i, but no difference compared with SGLT2i, suggesting that cardiovascular benefits of GLP-1RA use may extend to prevention for AF in patients with diabetes
When considering GLP-1 agonists for any indication, clinicians and patients must be aware of the established side effect profile of these medications
They demonstrate that a murine model of diabetes is associated with the development of ER stress in beta cells
